trimetazidine dihydrochloride Tablets, sustained release (SR) 20 mg, 35 mg, 60 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285
Manufacturer usually replies in 3 days
None